InfuSystem Holdings
INFU · NYSE American
About INFU
- Employees
- 467
- Headquarters
- Rochester Hills, Michigan
- Listed
- Jun 15, 2006
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- ir.infusystem.com
INFU key statistics
- Market cap
- 283.42M
- Price-earnings ratio
- 34.35
- Dividend yield
- —
- Average volume
- 113.63K
- Volume
- 116.60K
- Open price
- $13.77
- High today
- $14.28
- Low today
- $13.77
- 52 Week high
- $14.02
- 52 Week low
- $7.29
InfuSystem Holdings (INFU) at a glance
As of Oct 20, 2026, InfuSystem Holdings (INFU) shares are priced at $14.23, giving the company a market cap of 283.42M and a price-to-earnings ratio of 34.35.
Today the stock has traded between $13.77 and $14.28. The current price is 3.3% above the day's low and 0.4% below its high.
Volume so far is 116.60K shares, in line with the average of 113.63K shares a day.
Over the past year InfuSystem Holdings has ranged from $7.29 to $14.02, and now sits 103% of the way up that range.
InfuSystem Holdings met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.15 per share against an estimate of $0.1071.
The average analyst price target is $17.17, 20.7% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $15.15
- Now
- $14.23
- High
- $18.90
INFU earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 69.1% on average.
- Q3 FY24: reported $0.08 per share against an estimate of $0.0645
- Q4 FY24: reported $0.04 per share against an estimate of $0.077
- Q1 FY25: reported -$0.01 per share against an estimate of -$0.0408
- Q2 FY25: reported $0.12 per share against an estimate of $0.0367
- Q3 FY25: reported $0.11 per share against an estimate of $0.0816
- Q4 FY25: reported $0.10 per share against an estimate of $0.0738
- Q1 FY26: reported $0.05 per share against an estimate of $0.0341
- Q2 FY26: reported $0.15 per share against an estimate of $0.1071
INFU news
- Press releaseBusiness Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releaseBusiness Wire
InfuSystem Announces Financial Results for Second Quarter 2026
- Press releaseBusiness Wire
InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026
- Press releaseBusiness Wire
InfuSystem Announces $20 Million Stock Repurchase Program
- Press releaseBusiness Wire
InfuSystem Announces Financial Results for First Quarter 2026
- Press releaseBusiness Wire
InfuSystem to Report First Quarter 2026 Financial Results on May 7, 2026
- Press releaseBusiness Wire
InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026
Similar companies
Companies in the same industry as InfuSystem Holdings
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.